Authors:
HUTSON PR
TUTSCH KD
RAGO R
ARZOOMANIAN R
ALBERTI D
POMPLUN M
CHURCH D
MARNOCHA R
CHENG AL
KEHRLI N
WILDING G
Citation: Pr. Hutson et al., RENAL CLEARANCE, TISSUE DISTRIBUTION, AND CA-125 RESPONSES IN A PHASE-I TRIAL OF SURAMIN, Clinical cancer research, 4(6), 1998, pp. 1429-1436
Authors:
KUO ML
SHEN SC
YANG CH
CHUANG SE
CHENG AL
HUANG TS
Citation: Ml. Kuo et al., BCL-2 PREVENTS TOPOISOMERASE-II INHIBITOR GL331-INDUCED APOPTOSIS IS MEDIATED BY DOWN-REGULATION OF POLY(ADP-RIBOSE)POLYMERASE ACTIVITY, Oncogene, 17(17), 1998, pp. 2225-2234
Authors:
YEH KH
CHENG AL
LIN JF
MA IF
HSU CH
LU YS
CHEN YC
Citation: Kh. Yeh et al., SEQUENCE-DEPENDENT SYNERGISM OF PACLITAXEL AND 5-FLUOROURACIL IN THE TREATMENT OF GASTRIC-CANCER - IN-VITRO AND PILOT CLINICAL-STUDIES, Annals of oncology, 9, 1998, pp. 225-225
Citation: Al. Cheng et al., CISPLATIN, ETOPOSIDE, AND WEEKLY HIGH-DOSE 5-FLUOROURACIL AND LEUCOVORIN INFUSION (PE-HDFL) - A VERY EFFECTIVE REGIMEN WITH GOOD PATIENTS COMPLIANCE FOR ADVANCED GASTRIC-CANCER, Anticancer research, 18(2B), 1998, pp. 1267-1272
Authors:
YEH KH
CHEN YC
YEH SH
CHEN CP
LIN JTL
CHENG AL
Citation: Kh. Yeh et al., DETECTION OF CIRCULATING CANCER-CELLS BY NESTED REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION OF CYTOKERATIN-19 (K19)-POSSIBLE CLINICAL-SIGNIFICANCE IN ADVANCED GASTRIC-CANCER, Anticancer research, 18(2B), 1998, pp. 1283-1286
Citation: Kh. Yeh et Al. Cheng, HIGH-DOSE TAMOXIFEN REVERSES DRUG-RESISTANCE TO CISPLATIN AND ETOPOSIDE IN A PATIENT WITH ADVANCED LARGE-CELL CARCINOMA OF LUNG (VOL 17, PG1341, 1997), Anticancer research, 18(1A), 1998, pp. 93-93
Authors:
YEH KH
CHEN CL
SHUN CT
LIN JT
LEE WJ
LEE PH
CHEN YC
CHENG AL
Citation: Kh. Yeh et al., RELATIVELY LOW EXPRESSION OF MULTIDRUG RESISTANCE-1 (MDR-1) AND ITS POSSIBLE CLINICAL IMPLICATION IN GASTRIC CANCERS, Journal of clinical gastroenterology, 26(4), 1998, pp. 274-278
Authors:
YEH KH
LIN MT
LIN DT
TANG JL
LUI LT
LIN JF
CHANG YS
CHENG AL
YU SC
CHANG KJ
CHEN YC
Citation: Kh. Yeh et al., HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL (PBSC) SUPPORT USING AN INNOVATIVE MOBILIZATION REGIMEN IN PATIENTS WITH HIGH-RISK PRIMARY OR CHEMORESPONSIVE METASTATIC BREAST CANCERS, Breast cancer research and treatment, 49(3), 1998, pp. 237-244
Authors:
YEH KH
SHUN CT
CHEN CL
LIN JT
LEE WJ
LEE PH
CHEN YC
CHENG AL
Citation: Kh. Yeh et al., HIGH EXPRESSION OF THYMIDYLATE SYNTHASE IS ASSOCIATED WITH THE DRUG-RESISTANCE OF GASTRIC-CARCINOMA TO HIGH-DOSE 5-FLUOROURACIL-BASED SYSTEMIC CHEMOTHERAPY, Cancer, 82(9), 1998, pp. 1626-1631
Authors:
CHENG AL
YEH KH
UEN WC
HUNG RL
LIU MY
WANG CH
Citation: Al. Cheng et al., SYSTEMIC CHEMOTHERAPY ALONE FOR PATIENTS WITH NON-ACQUIRED IMMUNODEFICIENCY SYNDROME-RELATED CENTRAL-NERVOUS-SYSTEM LYMPHOMA - A PILOT-STUDY OF THE BOMES PROTOCOL, Cancer, 82(10), 1998, pp. 1946-1951
Citation: Kh. Yeh et Al. Cheng, GASTRIC-CANCER ASSOCIATED WITH ACUTE DISSEMINATED INTRAVASCULAR COAGULATION - SUCCESSFUL INITIAL TREATMENT WITH WEEKLY 24-HOUR INFUSION OF HIGH-DOSE 5-FLUOROURACIL AND LEUCOVORIN, British Journal of Haematology, 100(4), 1998, pp. 769-772
Citation: Kh. Yeh et Al. Cheng, 5-FLUOROURACIL RELATED ENCEPHALOPATHY - AT LEAST 2 DISTINCT PATHOGENETIC MECHANISMS EXIST - REPLY, British Journal of Cancer, 77(10), 1998, pp. 1711-1712
Authors:
CHENG AL
CHUANG SE
FINE RL
YEH KH
LIAO CM
LAY JD
CHEN DS
Citation: Al. Cheng et al., INHIBITION OF THE MEMBRANE TRANSLOCATION AND ACTIVATION OF PROTEIN-KINASE-C, AND POTENTIATION OF DOXORUBICIN-INDUCED APOPTOSIS OF HEPATOCELLULAR-CARCINOMA CELLS BY TAMOXIFEN, Biochemical pharmacology, 55(4), 1998, pp. 523-531
Citation: Al. Cheng et al., FACTORS ASSOCIATED WITH THE THERAPEUTIC EFFICACY OF RETINOIC ACIDS ONMALIGNANT-LYMPHOMAS, Journal of the Formosan Medical Association, 96(7), 1997, pp. 525-534
Authors:
HSU C
YEH KH
HONG RL
YANG CH
LIN MT
CHEN YC
CHENG AL
Citation: C. Hsu et al., MVP (MITOMYCIN-C, VINBLASTINE, CISPLATIN) SALVAGE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY METASTATIC BREAST-CANCER, Journal of the Formosan Medical Association, 96(3), 1997, pp. 185-188
Citation: Yy. Chou et al., EXPRESSION OF P-GLYCOPROTEIN AND P53 IN ADVANCED HEPATOCELLULAR-CARCINOMA TREATED BY SINGLE-AGENT CHEMOTHERAPY - CLINICAL CORRELATION, Journal of gastroenterology and hepatology, 12(8), 1997, pp. 569-575
Authors:
WANG YJ
PAN MH
CHENG AL
LIN LI
HO YS
HSIEH CY
LIN JK
Citation: Yj. Wang et al., STABILITY OF CURCUMIN IN BUFFER SOLUTIONS AND CHARACTERIZATION OF ITSDEGRADATION PRODUCTS, Journal of pharmaceutical and biomedical analysis, 15(12), 1997, pp. 1867-1876
Authors:
WU MS
SHEU JC
SHUN CT
LEE WJ
WANG JT
WANG TH
CHENG AL
LIN JT
Citation: Ms. Wu et al., INFREQUENT HMSH2 MUTATIONS IN SPORADIC GASTRIC ADENOCARCINOMA WITH MICROSATELLITE INSTABILITY, Cancer letters, 112(2), 1997, pp. 161-166
Citation: Ml. Kuo et al., TRANSFORMING-GROWTH-FACTOR BETA-1 ATTENUATES CERAMIDE-INDUCED CPP32 YAMA ACTIVATION AND APOPTOSIS IN HUMAN LEUKEMIC HL-60 CELLS/, Biochemical journal, 327, 1997, pp. 663-667
Authors:
YEH KH
CHENG AL
LIN MT
HONG RL
HSU CH
LIN JF
CHANG KJ
LEE PH
CHEN YC
Citation: Kh. Yeh et al., A PHASE-II STUDY OF WEEKLY 24-HOUR INFUSION OF HIGH-DOSE 5-FLUOROURACIL AND LEUCOVORIN (HDFL) IN THE TREATMENT OF RECURRENT OR METASTATIC COLORECTAL CANCERS, Anticancer research, 17(5B), 1997, pp. 3867-3871
Authors:
YEH KH
CHENG AL
SU IJ
LIN MT
TIEN HF
SHEN MC
WANG CH
CHEN YC
Citation: Kh. Yeh et al., PROGNOSTIC-SIGNIFICANCE OF IMMUNOPHENOTYPES IN ADULT LYMPHOBLASTIC LYMPHOMAS, Anticancer research, 17(3C), 1997, pp. 2269-2272
Citation: Kh. Yeh et Al. Cheng, HIGH-DOSE TAMOXIFEN REVERSES DRUG-RESISTANCE TO CISPLATIN AND ETOPOSIDE IN A PATIENT WITH ADVANCED LARGE-CELL CARCINOMA OF LUNG, Anticancer research, 17(2B), 1997, pp. 1341-1343